WFSBP 2019 Preliminary Program

WFSBP 2019 9 Monday, 3 June 2019 / Preliminary Scientific Program Schedule 8:00 S-01 Combining neu- roimaging data- sets to assess the neuroanatomy of psychosis and Bipolar Disorder (BD) S-02 Rapid-acting antidepressants: Current practice, predictive markers and neurobiological mechanisms S-03 Compensa- tory brain responses in the emergence and development of psychosis S-04 Immune modulation in mood disorders: Rationale and novel treatment options S-05 Opiate agonist therapies: Drugs, modes of application and clinical targets S-06 Comorbidity of adult ADHD and treatment- resistant depression: Augmentation with methyl- phenidate WS-01 Molecular and bio-markers in psychological diversity: Bet- ween psycho- logical traits and psychiatric disorders S-82 Epidemiological, socio-demo- graphic, clinical and therapeutic differences in Bi- polar Disorders among different countries 8:30 9:00 9:30 10:00 Plenary Lecture PL-01 Telomeres: What they do – and don’t – tell us 10:30 11:00 11:30 D-01 Gut microbes are the future of psychopharma- cological revolution S-07 What’s up with mixed states in Bipolar Disorder (BD) and Major Depression? S-08 Predicting diag- nosis and treatment in neuropsychiatric disorders with pattern recogni- tion algorithms S-09 Immune dys- regulation and white matter disruption: Converging pathophysiol- ogy in Bipolar Disorder (BD) S-10 Autoimmune psychosis and mild enceph- alitis: New challenges for psychiatry WS-02 Genetic and neurological bases of inter- net and game addiction WS-10 Biomarkers for psychiatric dis- orders: Recent developments and update Free Com- munication 12:00 12:30 13:00 Satellite Symposia Guided Poster Tours 13:30 14:00 14:30 15:00 TFS-01 Pharmacogene- tics, therapeutic drug monitoring and brain imag- ing methods as tools for optimizing antidepressants in psychiatry S-11 Affective disorders – from bench to guidelines: A translational view S-12 The prediction of treatment response in affective and psychotic disorders: From the molecule to the clinical phenotype S-13 Relevant neuro- imaging bio- markers in off- spring of parents with Bipolar Disorders (BD) WS-03 Interface of artificial intelligence, computation and machine learning in child and adolescent psychiatry S-14 The impact of negative symp- toms on patient outcomes ES-01 Educational Session Basic research Free Com- munication 15:30 16:00 16:30 17:00 S-15 Treatment-resis- tant depression (TRD) S-16 Current research on the use of cannabinoids and its treatment S-17 Dealing with agitation in every day clinical practice S-18 Brain ultrastruc- ture and neuro- nal functional alterations in Bipolar Disorder (BP): Towards an in vivo “micros- copy” S-19 The microbiome across the anxiety spectrum S-20 Novel environ- mental risks for impaired spine development in neuropsychiatry diseases Free Com- munication 17:30 18:00 18:30 Registration Counter Poster Exhibition Technical Exhibition 07:30–18:30 09:00–17:00 09:00–17:00

RkJQdWJsaXNoZXIy Mzg2Mjgy